150 related articles for article (PubMed ID: 35801299)
21. Antenatal diagnosis of cardio-facio-cutaneous syndrome: Prenatal characteristics and contribution of fetal facial dysmorphic signs in utero. About a case and review of literature.
Biard JM; Steenhaut P; Bernard P; Race V; Sznajer Y
Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():232-241. PubMed ID: 31336229
[TBL] [Abstract][Full Text] [Related]
22. Status epilepticus in BRAF-related cardio-facio-cutaneous syndrome: Focus on neuroimaging clues to physiopathology.
Musto E; Gambardella ML; Perulli M; Quintiliani M; Veredice C; Verdolotti T; Berté G; Leoni C; Onesimo R; Pulitanò SM; Tartaglia M; Zampino G; Contaldo I; Battaglia DI
Epilepsia Open; 2024 Feb; 9(1):258-267. PubMed ID: 37943120
[TBL] [Abstract][Full Text] [Related]
23. Cardio-facio-cutaneous syndrome: does genotype predict phenotype?
Allanson JE; Annerén G; Aoki Y; Armour CM; Bondeson ML; Cave H; Gripp KW; Kerr B; Nystrom AM; Sol-Church K; Verloes A; Zenker M
Am J Med Genet C Semin Med Genet; 2011 May; 157C(2):129-35. PubMed ID: 21495173
[TBL] [Abstract][Full Text] [Related]
24. Clinical and molecular spectra of BRAF-associated RASopathy.
Lee Y; Choi Y; Seo GH; Kim GH; Choi IH; Keum C; Ko JM; Cheon CK; Jeon J; Choi JH; Yoo HW; Lee BH
J Hum Genet; 2021 Apr; 66(4):389-399. PubMed ID: 33040082
[TBL] [Abstract][Full Text] [Related]
25. A cardio-facio-cutaneous syndrome case with tight Achilles tendons.
Hazan F; Aykut A; Hizarcioglu M; Tavli V; Onay H; Ozkinay F
Genet Couns; 2012; 23(2):305-11. PubMed ID: 22876591
[TBL] [Abstract][Full Text] [Related]
26. Adult mice expressing a Braf Q241R mutation on an ICR/CD-1 background exhibit a cardio-facio-cutaneous syndrome phenotype.
Moriya M; Inoue S; Miyagawa-Tomita S; Nakashima Y; Oba D; Niihori T; Hashi M; Ohnishi H; Kure S; Matsubara Y; Aoki Y
Hum Mol Genet; 2015 Dec; 24(25):7349-60. PubMed ID: 26472072
[TBL] [Abstract][Full Text] [Related]
27. Costello and cardio-facio-cutaneous syndromes: Moving toward clinical trials in RASopathies.
Rauen KA; Banerjee A; Bishop WR; Lauchle JO; McCormick F; McMahon M; Melese T; Munster PN; Nadaf S; Packer RJ; Sebolt-Leopold J; Viskochil DH
Am J Med Genet C Semin Med Genet; 2011 May; 157C(2):136-46. PubMed ID: 21495172
[TBL] [Abstract][Full Text] [Related]
28. Molecular and clinical characterization of cardio-facio-cutaneous (CFC) syndrome: overlapping clinical manifestations with Costello syndrome.
Narumi Y; Aoki Y; Niihori T; Neri G; Cavé H; Verloes A; Nava C; Kavamura MI; Okamoto N; Kurosawa K; Hennekam RC; Wilson LC; Gillessen-Kaesbach G; Wieczorek D; Lapunzina P; Ohashi H; Makita Y; Kondo I; Tsuchiya S; Ito E; Sameshima K; Kato K; Kure S; Matsubara Y
Am J Med Genet A; 2007 Apr; 143A(8):799-807. PubMed ID: 17366577
[TBL] [Abstract][Full Text] [Related]
29. Non-hodgkin lymphoma in a patient with cardiofaciocutaneous syndrome.
Ohtake A; Aoki Y; Saito Y; Niihori T; Shibuya A; Kure S; Matsubara Y
J Pediatr Hematol Oncol; 2011 Dec; 33(8):e342-6. PubMed ID: 20523244
[TBL] [Abstract][Full Text] [Related]
30. Two novel germline KRAS mutations: expanding the molecular and clinical phenotype.
Stark Z; Gillessen-Kaesbach G; Ryan MM; Cirstea IC; Gremer L; Ahmadian MR; Savarirayan R; Zenker M
Clin Genet; 2012 Jun; 81(6):590-4. PubMed ID: 21797849
[TBL] [Abstract][Full Text] [Related]
31. Brain structural changes in patients with cardio-facio-cutaneous syndrome: effects of BRAF gene mutation and epilepsy on brain development. A case-control study by quantitative magnetic resonance imaging.
Calandrelli R; Pilato F; Panfili M; Battaglia D; Gambardella ML; Colosimo C
Neuroradiology; 2022 Jan; 64(1):185-195. PubMed ID: 34309696
[TBL] [Abstract][Full Text] [Related]
32. Obstetrical and neonatal outcomes of cardio-facio-cutaneous syndrome: Prenatal consequences of Ras/MAPK dysregulation.
Jelin AC; Mahle A; Tran SH; Sparks TN; Rauen KA
Am J Med Genet A; 2023 Feb; 191(2):323-331. PubMed ID: 36308388
[TBL] [Abstract][Full Text] [Related]
33. Leukemia in Cardio-facio-cutaneous (CFC) syndrome: a patient with a germline mutation in BRAF proto-oncogene.
Makita Y; Narumi Y; Yoshida M; Niihori T; Kure S; Fujieda K; Matsubara Y; Aoki Y
J Pediatr Hematol Oncol; 2007 May; 29(5):287-90. PubMed ID: 17483702
[TBL] [Abstract][Full Text] [Related]
34. Fetal autopsy findings of cardiofaciocutaneous syndrome with a unique BRAF mutation.
Terry J; Rauen KA; Nowaczyk MJ
Pediatr Dev Pathol; 2014; 17(1):59-63. PubMed ID: 24303953
[TBL] [Abstract][Full Text] [Related]
35. Mutation and phenotypic spectrum in patients with cardio-facio-cutaneous and Costello syndrome.
Schulz AL; Albrecht B; Arici C; van der Burgt I; Buske A; Gillessen-Kaesbach G; Heller R; Horn D; Hübner CA; Korenke GC; König R; Kress W; Krüger G; Meinecke P; Mücke J; Plecko B; Rossier E; Schinzel A; Schulze A; Seemanova E; Seidel H; Spranger S; Tuysuz B; Uhrig S; Wieczorek D; Kutsche K; Zenker M
Clin Genet; 2008 Jan; 73(1):62-70. PubMed ID: 18042262
[TBL] [Abstract][Full Text] [Related]
36. Craniofacial and dental development in Costello syndrome.
Goodwin AF; Oberoi S; Landan M; Charles C; Massie JC; Fairley C; Rauen KA; Klein OD
Am J Med Genet A; 2014 Jun; 164A(6):1425-30. PubMed ID: 24668879
[TBL] [Abstract][Full Text] [Related]
37. A rare coincidence: the long QT syndrome and cardio-facio-cutaneous syndrome.
Giray D; Donmez YN; Epcacan S; Goktas E
Cardiol Young; 2020 Aug; 30(8):1209-1211. PubMed ID: 32635955
[TBL] [Abstract][Full Text] [Related]
38. Severe neuroglycopenic symptoms due to nonketotic hypoglycemia in children with cardio-facio-cutaneous syndrome.
Shiohama T; Fujii K; Kosaki R; Watanabe Y; Uchida T; Hagiwara S; Kinoshita K; Sugita K; Aoki Y; Shimojo N
Am J Med Genet A; 2022 Dec; 188(12):3505-3509. PubMed ID: 35943247
[TBL] [Abstract][Full Text] [Related]
39. Oculoectodermal syndrome is a mosaic RASopathy associated with KRAS alterations.
Peacock JD; Dykema KJ; Toriello HV; Mooney MR; Scholten DJ; Winn ME; Borgman A; Duesbery NS; Hiemenga JA; Liu C; Campbell S; Nickoloff BP; Williams BO; Steensma M
Am J Med Genet A; 2015 Jul; 167(7):1429-35. PubMed ID: 25808193
[TBL] [Abstract][Full Text] [Related]
40. Activated Braf induces esophageal dilation and gastric epithelial hyperplasia in mice.
Inoue SI; Takahara S; Yoshikawa T; Niihori T; Yanai K; Matsubara Y; Aoki Y
Hum Mol Genet; 2017 Dec; 26(23):4715-4727. PubMed ID: 28973166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
